Elaine K. Sorg
Sr. V.P., U.S. Commercial Ops., AbbVie.
Companies
- Artiva Biotherapeutics, Inc.Board member Feb 19, 2026 to now1
- AbbVieSr. V.P., U.S. Commercial Ops. Nov 19, 2020 to Apr 27, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 25, 2023Sold 6,130 shares at $165.00 of AbbVie3
- Apr 25, 2023Exercised options 6,130 shares at $144.54 of AbbVie3
- Apr 17, 2023Sold 500 shares at $162.04 of AbbVie4
- Apr 17, 2023Sold 6,999 shares at $161.64 of AbbVie4
- Apr 3, 2023Sold 15,002 shares at $160.03 of AbbVie5
- Apr 3, 2023Exercised options 15,002 shares at $93.50 of AbbVie5
- Mar 1, 2023Sold 15,003 shares at $155.00 of AbbVie6
- Mar 1, 2023Exercised options 15,003 shares at $93.50 of AbbVie6
- Feb 28, 2023Shares withheld for tax 19,850 shares at $154.28 of AbbVie6
- Feb 21, 2023Sold 8,420 shares at $151.29 of AbbVie7
- Feb 21, 2023Sold 6,901 shares at $150.74 of AbbVie7
- Feb 21, 2023Exercised options 15,321 shares at $105.92 of AbbVie7
- Feb 16, 2023Granted 3,874 shares of AbbVie7
- Feb 16, 2023Granted 4,658 shares of AbbVie7
- Feb 16, 2023Granted 6,861 shares of AbbVie7
- Feb 16, 2023Granted 29,410 shares of AbbVie7
- Mar 1, 2022Sold 700 shares at $149.07 of AbbVie8
- Mar 1, 2022Sold 3,451 shares at $148.59 of AbbVie8
- Mar 1, 2022Sold 2,333 shares at $147.59 of AbbVie8
- Feb 25, 2022Shares withheld for tax 11,125 shares at $149.54 of AbbVie8
- Feb 17, 2022Granted 10,377 shares of AbbVie9
- Feb 17, 2022Granted 4,075 shares of AbbVie9
- Feb 17, 2022Granted 6,861 shares of AbbVie9
- Feb 17, 2022Granted 2,530 shares of AbbVie9
- Feb 17, 2022Granted 11,642 shares of AbbVie9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Apr 19, 2023
- 5SEC EDGARForm 4 filed Apr 5, 2023
- 6SEC EDGARForm 4 filed Mar 2, 2023
- 7SEC EDGARForm 4 filed Feb 21, 2023
- 8SEC EDGARForm 4 filed Mar 1, 2022
- 9SEC EDGARForm 4 filed Feb 22, 2022